The costs of vaping ought to be reduced for smokers in developing countries as an urgent “human rights issue”, scientific study has told a pro-tobacco conference in London.
Addressing a 300-strong audience of tobacco and vaping industry representatives, Helen Redmond, a specialist in substance use at New York City University’s Silver School of Social Work, said people in poor countries really should not be priced out of nicotine-based products that could enable them to to give up smoking.
Redmond compared the medicinal qualities of nicotine with cannabis and stressed “the have to get vaping to the poorest, who require it most”.
“It’s a human rights issue – being a harm reduction device, prices have to fall,” she said. “Nicotine is not a dirty drug, it will help with depression and anxiety.”
Academics on the 2018 global tobacco and nicotine forum called for more research to the possible medical advantages of nicotine as well as a focus on the progression of innovative nicotine-based products that will provide a “smoke-free society” and lower the harmful results of cigarettes.
Viscount Matt Ridley, an author and member of your home of Lords, joined the chorus of experts promoting vaping as a kind of harm reduction, arguing that subjecting best e cigs on the market to the same workplace restrictions as smoking might be thought of as an infringement of an individual’s human rights.
“We should treat vaping in the same way that we treat access to mobile phones,” said Ridley. “The best practice to get people to quit [smoking] is always to innovate with technology”.
Ridleytold the conference that, inspite of the industry’s continued focus on promoting nicotine-based products as a form of harm reduction, public opinion was moving far from vaping because of media “scare stories”. He compared the industry’s plight, particularly in the US, for that faced by “bootleggers and baptists during prohibition”.
Clive Bates, director of advocacy group Counterfactual, described the views of anti-tobacco campaigners as “hostile and focused”, accusing them of getting rival commercial interests using a goal of “annihilating” the industry. Warning from the damage brought on by “those having a vested desire for causing alarm”, he said that although critics laboured to generate evidence to “maintain the narrative of harm”, technological advances meant the transition to vape-type products was prone to become mandatory rather than voluntary.
You can find 1.1 billion smokers worldwide and 6 million die every year as being a direct reaction to smoking. Another 890,000 people a year die prematurely as a result of second-hand smoke, in accordance with the World Health Organization.
One particular cigarette contains more than 200 carcinogenic chemicals, along with the addictive stimulant nicotine. Scientists and academics have up to now neglected to reach agreement on advantages and disadvantages of long-term nicotine use.
In a plenary session, clinical psychologist Karl Fagerström called for research in to the positive benefits of nicotine, which he believes can aid people suffering from Alzheimer’s and depression. Also, he advised wgferg the market should move from combustible to nicotine-based products.
“No the initial one is interested in establishing what some great benefits of smoking nicotine are,” Fagerström said.
Martin Jarvis, professor of health psychology at University College London, saidthe US was moving towards prohibition-type enforcement, with all the Food and Drug Administration willing to reduce the degree of nicotine in cigarettes.
“Society doesn’t understand nicotine,” said Jarvis, “because they believe that it is particularly bad.”
But Jarvis said “describing nicotine for being addictive is justified”, adding that “80% of smokers wished they never started”.